Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank
Journal of Cancer Research and Clinical Oncology · 24.08.2024 · 150 (8)
DOI: 10.1007/s00432-024-05919-8 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 24.08.2024. Verfasst von Chuang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Liebigstr. 20, D-04103, Leipzig, Germany. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Insulin Resistance, Biological Specimen Banks. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Leipzig.
Abstract (Originalsprache)
Purpose
This study explored the association between triglyceride-glucose (TyG), TyG index with body mass index (TyG-BMI), triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), metabolic score for insulin resistance (IR) (METS-IR) and the risk of esophageal cancer.
Methods
A total of 388,900 participants from the United Kingdom Biobank from 2006 to 2010 were included. Fine-Gray models, restricted cubic spline (RCS), and receiver operating characteristic (ROC) curves were used to assess the association between the four IR surrogates and the risk of esophageal cancer, specifically, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC).
Results
Ten years after recruitment, 0.16% (95%CI 0.11–0.26%) had esophageal cancer and 4.17% (95%CI 3.86–4.46%) are deceased. For each standard deviation increase in the TyG index, TyG-BMI, TG/HDL-C, and METS-IR, the risk of EAC increased by Hazard ratios (HR)1.16, 1.37, 1.08, and 1.36, respectively (all P < 0.05), while the risk of ESCC decreased by HRs 0.80, 0.67, 0.77, and 0.65, respectively. RCS analysis indicated that most relationships were nonlinear ( P < 0.05). ROC curves showed that METS-IR had a more robust diagnostic efficacy than TyG, TyG-BMI, and TG/HDL-C.
Conclusion
TyG index, TyG-BMI, TG/HDL-C, and METS-IR were closely associated with the risk of EAC and ESCC. Additionally, METS-IR surpassed the other three IR indices in predicting and diagnosing the risks of EAC and ESCC. The METS-IR is expected to become a more effective metric for identifying populations at early risk of esophageal cancer and for improving risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Liebigstr. 20, D-04103, Leipzig, Germany.
- Medical Faculty, University of Leipzig, Leipzig, Germany.
- Institute of Biostatistics and Clinical Research, University of Muenster, Muenster, Germany.
- Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, Liebigstr. 20, D-04103, Leipzig, Germany. rene.thieme@medizin.uni-leipzig.de.
Förderung
- Universitätsklinikum Leipzig
Zitieren
APA
Yang, C., Cheng, W., Plum, P. S., Köppe, J., Gockel, I., & Thieme, R. (2024). Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank. Journal of Cancer Research and Clinical Oncology, 150(8). https://doi.org/10.1007/s00432-024-05919-8
Vancouver
Yang C, Cheng W, Plum PS, Köppe J, Gockel I, Thieme R. Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank. Journal of Cancer Research and Clinical Oncology. 2024;150(8). doi:10.1007/s00432-024-05919-8
BibTeX
@article{Yang2024,
author = {Yang, Chuang and Cheng, Wenke and Plum, Patrick S and Köppe, Jeanette and Gockel, Ines and Thieme, René},
title = {Association between four insulin resistance surrogates and the risk of esophageal cancer: a prospective cohort study using the UK Biobank},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
volume = {150},
number = {8},
doi = {10.1007/s00432-024-05919-8}
}
EUVIMED